好消息？ RECEIPT OF PRC REGULATORY APPROVALS FOR COMMERCIAL PRODUCTIONhttp://info.sgx.com/webcoranncatth.nsf/VwAttachments/Att_B0EB1DBA47B6E9C6482577C700360CA1/$file/CAH_SGXAnn_BiweiAntai_PRCApprovalVaccine.pdf?openelement - RECEIPT OF PRC REGULATORY APPROVALS FOR COMMERCIAL PRODUCTION AND SALE OF ANIMAL FOOT-AND-MOUTH DISEASE (“FMD”) VACCINE The Directors of the Company are pleased to inform shareholders that the Company’s subsidiary, Biwei Antai, has received regulatory approvals from the PRC Ministry of Agriculture (“MOA”) to commence commercial production and sale of its FMD vaccines. The administrative issuance of the relevant drug numbers by MOA is expected to follow in due course. With the receipt of such approvals, the Company will be able to participate in tenders for the purchase of such vaccines which are called by regional government animal disease control centres in the PRC.